This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.
Company Filing History:
1 out of 834,350 Years Active: 2006
Title: Gregory D Lundquist: Innovator in Pharmaceutical Compounds
Introduction
Gregory D Lundquist is a notable inventor based in Salem, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on piperazine derivatives. His research focuses on compounds that have potential therapeutic applications.
Latest Patents
Lundquist holds a patent for piperazine derivatives, which relates to compounds of the formula I and their pharmaceutically acceptable forms. The invention is directed at pharmaceutical compositions that include these compounds and a suitable carrier. Additionally, it outlines methods for using these compounds to treat or prevent disorders by antagonizing the CCR1 receptor in mammals. This patent showcases his commitment to advancing medical science and improving treatment options.
Career Highlights
Throughout his career, Gregory D Lundquist has demonstrated a strong dedication to research and innovation. His work has led to the development of valuable pharmaceutical compounds that may have a significant impact on healthcare. With a focus on practical applications, he continues to contribute to the scientific community.
Collaborations
Lundquist has collaborated with notable colleagues, including Matthew Frank Brown and Laura Cook Blumberg. These partnerships have likely enhanced his research efforts and broadened the scope of his work in the pharmaceutical field.
Conclusion
Gregory D Lundquist is an accomplished inventor whose work on piperazine derivatives exemplifies the intersection of innovation and healthcare. His contributions are poised to make a lasting impact on the treatment of various disorders.